Investigating potential confounding by indication when considering the association between proton pump inhibitor use, infection, hepatic encephalopathy and mortality in hospitalised decompensated cirrhosis: a post-hoc analysis of the ATTIRE trial-Reference-Cited by-同舟云学术

Investigating potential confounding by indication when considering the association between proton pump inhibitor use, infection, hepatic encephalopathy and mortality in hospitalised decompensated cirrhosis: a post-hoc analysis of the ATTIRE trial

Published:2023-04 Issue: Volume:58 Page:101924
ISSN:2589-5370
Container-title:eClinicalMedicine
language:en
Short-container-title:eClinicalMedicine

Author:

China Louise^ORCID,Tittanegro Thais,Crocombe Dominic^ORCID,Forrest Ewan,Kallis Yiannis,Ryder Stephen D.,Wright Gavin,Freemantle Nick,O'Brien Alastair

Funder

Wellcome Trust

Department of Health and Social Care

Publisher

Elsevier BV

Subject

General Medicine

Reference39 articles.

1. Proton pump inhibitor treatment is associated with the severity of liver disease and increased mortality in patients with cirrhosis;Dultz;Aliment Pharmacol Ther,2015

2. Use and overuse of proton pump inhibitors in cirrhotic patients;Chavez-Tapia;Med Sci Monit,2008

3. PPIs are not associated with a lower incidence of portal-hypertension-related bleeding in cirrhosis;Garcia-Saenz-de-Sicilia;World J Gastroenterol,2010

4. Acid-suppressive therapy is associated with spontaneous bacterial peritonitis in cirrhotic patients: a meta-analysis;Deshpande;J Gastroenterol Hepatol,2013

5. Systematic review and meta-analysis of the possible association between pharmacological gastric acid suppression and spontaneous bacterial peritonitis;Khan;Eur J Gastroenterol Hepatol,2015

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proton pump inhibitor use and risk of hepatic encephalopathy: A multicentre study;JHEP Reports;2024-08

2. Letter: Risks of proton pump inhibitor treatment in cirrhotic patients;Alimentary Pharmacology & Therapeutics;2024-04-21

3. Risks of Proton Pump Inhibitors in Patients with Cirrhosis: Please Peruse the Indications;Digestive Diseases and Sciences;2023-11-15

4. Safe use of proton-pump inhibitors;Revista Española de Enfermedades Digestivas;2023